Medtronic plc (MDT) · Initial Holdings (Form 3) SEC Filing

=== SEC Form 3 — Statement of Changes in Beneficial Ownership === Document Type: 3 Period of Report: 2026-06-18 --- Issuer --- Name: Medtronic plc (MDT) CIK: 0001613103 --- Reporting Owner --- Name: Thompson Kweli CIK: 0002137804 Role: Officer (EVP & President, Neuroscience) --- Holdings --- [Holding #1] Security: Ordinary Shares Ownership: D (Direct) Footnotes: [F1] Includes 6,549 performance stock units that vested on April 24, 2026; 1,822 restricted stock units that vested on December 6, 2025; 3,742.990 restricted stock units that vest on July 31, 2026; 3,402.644 restricted stock units that vest on December 6, 2026; 9,911.187 restricted stock units that vest on July 29, 2027; 4,589.916 restricted stock units that vest on July 28, 2028. [Holding #2] Security: Performance Share Unit Ownership: D (Direct) Footnotes: [F4] Each PSU represents a contingent right to receive one share of Medtronic common stock. [F2] The performance share units ("PSUs") vest on December 6, 2026. [F2] The performance share units ("PSUs") vest on December 6, 2026. [F3] The number of shares to be issued in connection with the PSUs reported reflects the amount earned based on achievement of applicable performance criteria. The award remains subject to time-based vesting. [Holding #3] Security: Performance Share Units Ownership: D (Direct) Footnotes: [F4] Each PSU represents a contingent right to receive one share of Medtronic common stock. [F5] The PSUs vest on April 30, 2027. [F5] The PSUs vest on April 30, 2027. [F6] The number of shares to be issued in connection with PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,911.187 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. [Holding #4] Security: Performance Share Units Ownership: D (Direct) Footnotes: [F4] Each PSU represents a contingent right to receive one share of Medtronic common stock. [F7] The PSUs vest on April 28, 2028. [F7] The PSUs vest on April 28, 2028. [F8] The number of shares to be issued in connection with the PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,178.809 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. [Holding #5] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F9] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. [Holding #6] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F9] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. [Holding #7] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F9] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. [Holding #8] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F9] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. [Holding #9] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F9] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. [Holding #10] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F9] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. [Holding #11] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F9] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. [Holding #12] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F9] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. [Holding #13] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F9] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. [Holding #14] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F9] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. [Holding #15] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F9] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. --- Footnotes (Complete Index) --- F1: Includes 6,549 performance stock units that vested on April 24, 2026; 1,822 restricted stock units that vested on December 6, 2025; 3,742.990 restricted stock units that vest on July 31, 2026; 3,402.644 restricted stock units that vest on December 6, 2026; 9,911.187 restricted stock units that vest on July 29, 2027; 4,589.916 restricted stock units that vest on July 28, 2028. F2: The performance share units ("PSUs") vest on December 6, 2026. F3: The number of shares to be issued in connection with the PSUs reported reflects the amount earned based on achievement of applicable performance criteria. The award remains subject to time-based vesting. F4: Each PSU represents a contingent right to receive one share of Medtronic common stock. F5: The PSUs vest on April 30, 2027. F6: The number of shares to be issued in connection with PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,911.187 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F7: The PSUs vest on April 28, 2028. F8: The number of shares to be issued in connection with the PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,178.809 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F9: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. --- Signature --- /s/ /s/ Patricia Walesiewicz, attorney-in-fact (2026-06-26)